HI HCR172

Designates the week of May 3, 2020 as "Tardive Dyskinesia Awareness Week" in Hawaii.

Recognizes tardive dyskinesia as a movement disorder characterized by involuntary muscle movements that can develop from long-term use of dopamine receptor blocking agents used to treat mental illness and gastrointestinal disorders.

Notes that over 500,000 Americans suffer from tardive dyskinesia, with an estimated 10-30 percent risk for those taking dopamine receptor blocking agents for three months or longer.

Directs the Department of Education, Department of Health, and U.S. Department of Health and Human Services to increase public awareness and education about tardive dyskinesia.

Requires certified copies of the resolution to be sent to the Governor, Board of Education, Superintendent of Education, Director of Health, and U.S. Department of Health and Human Services.